FDA Still Feels Transvaginal Mesh Products Too Risky After Final Postmarketing Study
After reviewing the final postmarketing study on Coloplast transvaginal mesh, the FDA has determined the risks still outweigh the potential benefits.
After reviewing the final postmarketing study on Coloplast transvaginal mesh, the FDA has determined the risks still outweigh the potential benefits.
A transvaginal mesh lawsuit has been filed over an Ethicon Gynecare mesh which eroded through a woman's flesh
New postmarketing surveillance studies show Boston Scientific transvaginal mesh increase the risk of health complications for pelvic organ prolapse patients, without adding any additional effectiveness or safety over traditional surgical…
Two new studies provide more evidence that vaginal mesh carry few, if any, benefits, and that there is little which can be done to improve them.
A vaginal mesh lawsuit indicates Boston Scientific mesh devices caused severe injuries, complications and the need for surgery.
The FDA has banned the sale and distribution of transvaginal mesh products in the United States, saying they cannot guarantee the devices are safe or effective for women.
A new study finds that C-section deliveries lower the risk of pelvic floor disorders.
The FDA will hold an advisory meeting in February to help determine the future use of transvaginal mesh in the U.S., given the high risk of complications and the low…
The Scottish Parliament is considering a petition to ban all vaginal mesh in that country, due to the risk of complications and injuries.
The U.K. has temporarily paused the use of vaginal mesh for the treatment of stress urinary incontinence until a number of steps to avoid injuries and complications are taken.